GlassScriptPhysician profile
Christopher R Page
NPI 1568663862
$166,456.54
in general payments reported to CMS, 2019-2025
17 companies · $398 in 2025
The $398 reported for 2025 was more than what 89% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $156K · 2020: $132 · 2021: $7,683 · 2022: $1,690 · 2023: $25.49 · 2024: $43.49 · 2025: $398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $467.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $466.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Research & Development, LLC | $156,269.24 | 2019 | |
| Baudax Bio INC. | $7,486.38 | 2021 | |
| Dukal LLC | $1,666.66 | 2022 | |
| Heron Therapeutics, INC. | $204.73 | 2019-2024 | Aponvie, Zynrelef |
| Medtronic, INC. | $195.99 | 2021-2022 | |
| Medtronic USA, INC. | $152.38 | 2019-2020 | |
| Bausch & Lomb Americas INC. | $131.14 | 2025 | Envista Mx60 Iol |
| Alcon Vision LLC | $108.44 | 2025 | Unity |
| Chiesi USA, INC. | $44.04 | 2019-2020 | |
| Braintree Laboratories, INC. | $40.91 | 2025 | Suflave, Sutab |
| Abbvie INC. | $31.39 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.03 | 2025 | Entyvio |
| Lilly USA, LLC | $22.32 | 2025 | Omvoh |
| Rayner Intraocular Lenses Limited | $21.88 | 2025 | Omidria |
| Evoke Pharma, INC. | $19.96 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acelrx Pharmaceuticals, INC. | $19.51 | 2020 | |
| Ardelyx, INC. | $17.54 | 2025 | Ibsrela |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Page listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.